Regeneron

News

Doctor in the hand shows the scanning of the lung of the person.

NICE changes stance on Sanofi's Dupixent for severe asthma

18 months after saying "no" to regular NHS funding for Sanofi and Regeneron's Dupixent (dupilumab) for severe asthma in initial guidance, NICE has now backed the drug.

News

ESMO21: Libtayo extends survival in first-line NSCLC, challe...

There's no shortage of cancer immunotherapies trying to knock Merck & Co's Keytruda off the top of the tree in previously-untreated non-small cell lung cancer (NSCLC).

News

Illustration of a nerve cell on a colored background with light effects

EU panel rejects Pfizer's tanezumab for osteoarthritis pain

Any lingering hope that Pfizer may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor tanezumab looks to have been dashed after the EMA's human medicines committe

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

PROVENT trial puts AZ COVID antibody combo back on track

AstraZeneca's AZD7442 has shown that it can prevent COVID-19 infection when given to healthy patients – the first time this has been demonstrated by a long-acting antibody-based drug.

News

Novartis says trials back Beovu safety in diabetic eye disea...

There is plenty of evidence that Novartis' ophthalmology drug Beovu can match its rivals when it comes to efficacy, with less frequent dosing, but the big question facing the company is whe

News

Look out Dupixent, Lilly's lebrikizumab is on the march

Eli Lilly had a lot riding on its two phase 3 trials of IL-13 inhibitor lebrikizumab in atopic dermatitis (AD) – and it now looks like it has backed a winner.

NICE changes stance on Sanofi's Dupixent for severe asthma

ESMO21: Libtayo extends survival in first-line NSCLC, challe...

EU panel rejects Pfizer's tanezumab for osteoarthritis pain

PROVENT trial puts AZ COVID antibody combo back on track

Novartis says trials back Beovu safety in diabetic eye disea...

Look out Dupixent, Lilly's lebrikizumab is on the march

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Regeneron

Editor's Picks